Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Premiere Clinical Research
mi
from
Lakewood, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Premiere Clinical Research
mi
from
Lakewood, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Long Beach Center for Clinical Research
mi
from
Long Beach,, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Long Beach Center for Clinical Research
mi
from
Long Beach,, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
UCLA Kidney Transplant Research
mi
from
Los Angelas, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
UCLA Kidney Transplant Research
mi
from
Los Angelas, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
David Geffen School of Medicine Division of Nephrology
mi
from
Los Angelas, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
David Geffen School of Medicine Division of Nephrology
mi
from
Los Angelas, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Desert Oasis Healthcare Medical Group
mi
from
Palm Springs, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Desert Oasis Healthcare Medical Group
mi
from
Palm Springs, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Apex Research of Riverside
mi
from
Riverside, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Apex Research of Riverside
mi
from
Riverside, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
River City Clinical Research
mi
from
Sacramento, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
River City Clinical Research
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Samsun Clinic
mi
from
Santa Barbara, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Samsun Clinic
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Orange County Research Center
mi
from
Tustin, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Orange County Research Center
mi
from
Tustin, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Infosphere Clinical Research, Inc.
mi
from
West Hills, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Infosphere Clinical Research, Inc.
mi
from
West Hills, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Creekside Endocrine Associates PC
mi
from
Denver, CO
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Creekside Endocrine Associates PC
mi
from
Denver, CO
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Palm Spring Research Institute
mi
from
Hialeah, FL
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Palm Spring Research Institute
mi
from
Hialeah, FL
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
San Marcus Research Clinic
mi
from
Miami, FL
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
San Marcus Research Clinic
mi
from
Miami, FL
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Advanced Pharma CR
mi
from
Kendall Lakes-Lindgren Acres, FL
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Advanced Pharma CR
mi
from
Kendall Lakes-Lindgren Acres, FL
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Ormond Medical Arts Pharmaceutical Research
mi
from
Ormond Beach, FL
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Ormond Medical Arts Pharmaceutical Research
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Clincal Research of Central Florida
mi
from
Winter Haven, FL
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Clincal Research of Central Florida
mi
from
Winter Haven, FL
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
River Birch Research Alliance
mi
from
Blue Ridge, GA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
River Birch Research Alliance
mi
from
Blue Ridge, GA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Apex Medical Research
mi
from
Chicago, IL
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Apex Medical Research
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
University of Chicago Medical Center
mi
from
Chicago, IL
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
American Health Network of IN
mi
from
Avon, IN
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
American Health Network of IN
mi
from
Avon, IN
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
American Healthcare Network of Indiana
mi
from
Greenfield, IN
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
American Healthcare Network of Indiana
mi
from
Greenfield, IN
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Medstar Health Research Institute
mi
from
Hyattsville, MD
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Medstar Health Research Institute
mi
from
Hyattsville, MD
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Brigham and Women's Hosp
mi
from
Boston, MA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Harvard Medical School Beth Israel Deaconess Medical Center
mi
from
Boston, MA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Harvard Medical School Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Apex Medical Research, MI, Inc.
mi
from
Flint, MI
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Apex Medical Research, MI, Inc.
mi
from
Flint, MI
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Clinical Research Consultants (MO)
mi
from
Kansas City, MO
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Clinical Research Consultants (MO)
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
The Rogosin Institute
mi
from
, NY
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
The Rogosin Institute
mi
from
, NY
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Clinical Research Development Associates (NY)
mi
from
Rosedale, NY
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Clinical Research Development Associates (NY)
mi
from
Rosedale, NY
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
University of North Carolina School of Medicine
mi
from
Chapel Hill, NC
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
University of North Carolina School of Medicine
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Clinical Research Limited
mi
from
Canton, OH
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Clinical Research Limited
mi
from
Canton, OH
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Lynn Institute of Norman
mi
from
Norman, OK
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Lynn Institute of Norman
mi
from
Norman, OK
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
C.S.R.A. Renal Services
mi
from
Aiken, SC
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
C.S.R.A. Renal Services
mi
from
Aiken, SC
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Pharmacorp Clinical Trials
mi
from
Charleston, SC
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Pharmacorp Clinical Trials
mi
from
Charleston, SC
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Mountain View Clinical Research
mi
from
Greer, SC
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Mountain View Clinical Research
mi
from
Greer, SC
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Vanderbilt University Medical Center
mi
from
Nashville, TN
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Research Across America
mi
from
Northeast, TX
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Research Across America
mi
from
Northeast, TX
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Millenium Clinical Research Inc
mi
from
Houston, TX
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Millenium Clinical Research Inc
mi
from
Houston, TX
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Renal Associates
mi
from
San Antonio, TX
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Renal Associates
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Cetero
mi
from
San Antonio, TX
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Cetero
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
San Antonio Kidney Disease Center Physicians Group
mi
from
San Antonio, TX
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
San Antonio Kidney Disease Center Physicians Group
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Multicare Research Institute (WA)
mi
from
Tacoma, WA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Multicare Research Institute (WA)
mi
from
Tacoma, WA
Click here to add this to my saved trials
Blood Pressure in Dialysis Patients
Blood Pressure in Dialysis Patients (BID Study)
Status: Enrolling
Updated:  3/28/2012
Satellite Healthcare, Inc.
mi
from
San Jose, CA
Blood Pressure in Dialysis Patients
Blood Pressure in Dialysis Patients (BID Study)
Status: Enrolling
Updated: 3/28/2012
Satellite Healthcare, Inc.
mi
from
San Jose, CA
Click here to add this to my saved trials
Blood Pressure in Dialysis Patients
Blood Pressure in Dialysis Patients (BID Study)
Status: Enrolling
Updated:  3/28/2012
DCI Boston - Tufts
mi
from
Boston, MA
Blood Pressure in Dialysis Patients
Blood Pressure in Dialysis Patients (BID Study)
Status: Enrolling
Updated: 3/28/2012
DCI Boston - Tufts
mi
from
Boston, MA
Click here to add this to my saved trials
Blood Pressure in Dialysis Patients
Blood Pressure in Dialysis Patients (BID Study)
Status: Enrolling
Updated:  3/28/2012
DaVita
mi
from
Boston, MA
Blood Pressure in Dialysis Patients
Blood Pressure in Dialysis Patients (BID Study)
Status: Enrolling
Updated: 3/28/2012
DaVita
mi
from
Boston, MA
Click here to add this to my saved trials
Blood Pressure in Dialysis Patients
Blood Pressure in Dialysis Patients (BID Study)
Status: Enrolling
Updated:  3/28/2012
DCI Somerville
mi
from
Somerville, MA
Blood Pressure in Dialysis Patients
Blood Pressure in Dialysis Patients (BID Study)
Status: Enrolling
Updated: 3/28/2012
DCI Somerville
mi
from
Somerville, MA
Click here to add this to my saved trials
Blood Pressure in Dialysis Patients
Blood Pressure in Dialysis Patients (BID Study)
Status: Enrolling
Updated:  3/28/2012
Dialysis Clinic, Inc.- ABQ East
mi
from
Albuquerque, NM
Blood Pressure in Dialysis Patients
Blood Pressure in Dialysis Patients (BID Study)
Status: Enrolling
Updated: 3/28/2012
Dialysis Clinic, Inc.- ABQ East
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Blood Pressure in Dialysis Patients
Blood Pressure in Dialysis Patients (BID Study)
Status: Enrolling
Updated:  3/28/2012
Dialysis Clinic, Inc.
mi
from
Albuqueruqe, NM
Blood Pressure in Dialysis Patients
Blood Pressure in Dialysis Patients (BID Study)
Status: Enrolling
Updated: 3/28/2012
Dialysis Clinic, Inc.
mi
from
Albuqueruqe, NM
Click here to add this to my saved trials
Blood Pressure in Dialysis Patients
Blood Pressure in Dialysis Patients (BID Study)
Status: Enrolling
Updated:  3/28/2012
DCI Point Breeze
mi
from
Pittsburgh, PA
Blood Pressure in Dialysis Patients
Blood Pressure in Dialysis Patients (BID Study)
Status: Enrolling
Updated: 3/28/2012
DCI Point Breeze
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Blood Pressure in Dialysis Patients
Blood Pressure in Dialysis Patients (BID Study)
Status: Enrolling
Updated:  3/28/2012
DCI James Island
mi
from
Charleston, SC
Blood Pressure in Dialysis Patients
Blood Pressure in Dialysis Patients (BID Study)
Status: Enrolling
Updated: 3/28/2012
DCI James Island
mi
from
Charleston, SC
Click here to add this to my saved trials
Blood Pressure in Dialysis Patients
Blood Pressure in Dialysis Patients (BID Study)
Status: Enrolling
Updated:  3/28/2012
DCI Azalea Place
mi
from
North Charleston, SC
Blood Pressure in Dialysis Patients
Blood Pressure in Dialysis Patients (BID Study)
Status: Enrolling
Updated: 3/28/2012
DCI Azalea Place
mi
from
North Charleston, SC
Click here to add this to my saved trials